Meet the Leading Minds in Global CAR-TCR Development

2025 saw a renewed surge of investment in cell therapy; demonstrated recently in the cases of ArsenalBio and AvenCellsAstraZeneca and Esobiotec, and Bristol Myers Squibb and 2seventy bio. Everyone was looking to put their stake in the market forecast to reach $20.7 billion in 2030.

The industry was actively seeking to evaluate potential partners in order to secure long lasting support across pre-clinical testing and modelling services to improve translatability, through to reducing manufacturing costs to make treatments more accessible for patients.

With this came the need for global service providers looking to establish or consolidate their footprint. If you were a CDMO building out rapid and reliable manufacturing, a viral vector manufacturer, or pre-clinical and clinical CRO demonstrating cell therapy expertise, analytical service, or working in single cell and sequencingraw materials and more, our audience wanted to hear from you.

Partnership opportunities have now closed, but you can still be part of the industry's leading cell therapy conference, by registering your interest for 2026.

14 (1)

Why Should You Prioritize Partnering?

Brand Exposure

Position yourself as the industry’s go-to service provider by showcasing your cutting-edge solutions to a curated audience of senior cell therapy leaders. With leading service providers already confirming their involvement, don’t let your brand be the one to miss out

Structured & Bespoke Networking Opportunities

Make valuable connections with decision-makers and scientists to forge new strategic partnerships and consolidate existing relationships

Thought Leadership

Highlight your contributions to streamlining cell therapy manufacturing or pre-clinical development to our audience of technical and commercial leaders and decision makers

Harness Market Intelligence

As the field continues to evolve, so does the industry’s need for trusted partners. Stay ahead of the curve by gaining invaluable insight into recent trends to ensure your offerings meet their needs

Meet the Who’s Who of CAR-TCR

Gain exclusive access to a diverse audience of 100+ companies including commercial giants alongside pioneering start-ups, comprised of 800+ innovators and decision makers in a collective and collaborative forum

Audience Breakdown

Discovery

Meet CSOs, CEOs, Pre-clinical Development Scientists, Heads, VPs and Directors of Research and Biology

Our Audience Wants to Meet: 

Raw Material Providers, Apheresis/ Blood/ Biospecimen Banks, Genetic Engineering & Genetically Engineered Cell Lines Providers, Antibody Discovery Companies

Translational

Meet Global Heads and Presidents working on translational, pharmacology and biomarker development, and Global Heads of immunology and translational biology

Our Audience Wants to Meet:

CROs, Preclinical Model Providers, Genetic Engineering & Genetically Engineered Cell Lines Providers

Clinical Development

Meet VPs and Heads of Clinical Development, Clinical Trial Leads and Heads of Regulatory Development

Our Audience Wants to Meet:

CROs, Data Management Companies, Software Providers, Legal Firms, Regulatory Consulting Firms

Early-Stage Manufacturing

Meet CTOs, Heads of Process Development and Scientists focused on pre-clinical and early clinical manufacturing

Our Audience Wants to Meet: 

CDMO/CMO, Viral & Non-Viral Vector Manufacturers, Equipment Providers, Lab Rental/ Infrastructure Companies, Raw Material Providers

Late-Stage Manufacturing

Meet CTOs, Global Heads of Manufacturing and MSAT Scientists

Our Audience Wants to Meet: 

CDMO/CMO, Equipment Providers, Raw Material Providers, Logistics Companies, Transport Companies, Lab Rental/ Infrastructure Companies

Analytical Development

Meet VPs of Quality Control, Heads of Assay Developments and Scientists focusing on Analytical Development

Our Audience Wants to Meet:

Analytical Service Providers, Characterization/ Single Cell/ Sequencing Service Providers, Equipment Providers, Lab Rental/ Infrastructure Companies

Attending Companies Include

17 (2)
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

11
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

2 (1)
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.